Berkeley Lights Closes $95 Million Funding Round To Expedite Commercial Expansion And Platform Development For Cell Therapy Financing will also be used to drive R&D and further expand commercial activities for digital cell biology worldwide EMERYVILLE, Calif., October 15, 2018-- Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today the completion of a $95 million financing led by Nikon and backed by existing investors Sequoia Capital, Walden-Riverwood Ventures, Black Diamond Ventures, and Paxion Capital; and joined by new investors Cota Capital, KTB Network, Atinum Investment, Shangbay Capital, AJS BioTree Healthcare Fund, and Varian.